

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.05651269 |
| 2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.17110820 |
| 3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.17110820 |
| 4 | modulation by symbiont of host immune response (GO:0052553) | 5.17110820 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.17110820 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 5.17110820 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.17110820 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 4.93549295 |
| 9 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.88836961 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.72245285 |
| 11 | response to peptidoglycan (GO:0032494) | 4.43140498 |
| 12 | B cell receptor signaling pathway (GO:0050853) | 4.42406833 |
| 13 | negative regulation of cell killing (GO:0031342) | 4.40580348 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.40580348 |
| 15 | cellular response to interferon-beta (GO:0035458) | 4.24655410 |
| 16 | positive regulation of interferon-alpha production (GO:0032727) | 4.19509339 |
| 17 | defense response to protozoan (GO:0042832) | 4.19313150 |
| 18 | immunoglobulin mediated immune response (GO:0016064) | 4.15563608 |
| 19 | superoxide anion generation (GO:0042554) | 4.13983791 |
| 20 | cellular response to exogenous dsRNA (GO:0071360) | 4.11753838 |
| 21 | response to interferon-beta (GO:0035456) | 4.09514429 |
| 22 | type I interferon signaling pathway (GO:0060337) | 4.07416225 |
| 23 | cellular response to type I interferon (GO:0071357) | 4.07416225 |
| 24 | response to type I interferon (GO:0034340) | 4.01225146 |
| 25 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.98028882 |
| 26 | response to host immune response (GO:0052572) | 3.98028882 |
| 27 | regulation of interferon-alpha production (GO:0032647) | 3.92261037 |
| 28 | respiratory burst (GO:0045730) | 3.86681935 |
| 29 | regulation of regulatory T cell differentiation (GO:0045589) | 3.83014354 |
| 30 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.80659856 |
| 31 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.80659856 |
| 32 | regulation of gamma-delta T cell activation (GO:0046643) | 3.79300994 |
| 33 | detection of bacterium (GO:0016045) | 3.78130037 |
| 34 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.77681533 |
| 35 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.77416232 |
| 36 | response to interferon-alpha (GO:0035455) | 3.75451607 |
| 37 | negative regulation of viral genome replication (GO:0045071) | 3.73514846 |
| 38 | macrophage activation involved in immune response (GO:0002281) | 3.72724036 |
| 39 | cellular extravasation (GO:0045123) | 3.70697198 |
| 40 | response to interleukin-15 (GO:0070672) | 3.69833708 |
| 41 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.69537133 |
| 42 | neutrophil activation (GO:0042119) | 3.63219091 |
| 43 | regulation of RIG-I signaling pathway (GO:0039535) | 3.62489014 |
| 44 | granulocyte activation (GO:0036230) | 3.60517889 |
| 45 | cellular response to interleukin-15 (GO:0071350) | 3.60096896 |
| 46 | response to protozoan (GO:0001562) | 3.59303610 |
| 47 | mast cell activation (GO:0045576) | 3.58781183 |
| 48 | cytidine metabolic process (GO:0046087) | 3.58687490 |
| 49 | cytidine catabolic process (GO:0006216) | 3.58687490 |
| 50 | cytidine deamination (GO:0009972) | 3.58687490 |
| 51 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.57042710 |
| 52 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.55749170 |
| 53 | response to host (GO:0075136) | 3.54257530 |
| 54 | response to host defenses (GO:0052200) | 3.54257530 |
| 55 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.54257530 |
| 56 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.53171667 |
| 57 | negative regulation of interleukin-12 production (GO:0032695) | 3.53150556 |
| 58 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.51870659 |
| 59 | leukocyte degranulation (GO:0043299) | 3.48339010 |
| 60 | detection of molecule of bacterial origin (GO:0032490) | 3.48024205 |
| 61 | T-helper 1 type immune response (GO:0042088) | 3.44861267 |
| 62 | myeloid cell activation involved in immune response (GO:0002275) | 3.43375463 |
| 63 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.43063339 |
| 64 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.42127962 |
| 65 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.41746980 |
| 66 | detection of biotic stimulus (GO:0009595) | 3.41723311 |
| 67 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.41118111 |
| 68 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.41118111 |
| 69 | negative regulation of interleukin-17 production (GO:0032700) | 3.40275708 |
| 70 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.38442698 |
| 71 | reactive oxygen species biosynthetic process (GO:1903409) | 3.37559941 |
| 72 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.36345952 |
| 73 | myeloid dendritic cell activation (GO:0001773) | 3.36052134 |
| 74 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.35626434 |
| 75 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.28686045 |
| 76 | microglial cell activation (GO:0001774) | 3.26093629 |
| 77 | positive thymic T cell selection (GO:0045059) | 3.23888099 |
| 78 | positive regulation of antigen processing and presentation (GO:0002579) | 3.23719319 |
| 79 | regulation of chemokine biosynthetic process (GO:0045073) | 3.23694646 |
| 80 | positive regulation of lymphocyte migration (GO:2000403) | 3.22982090 |
| 81 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.22948280 |
| 82 | positive regulation of mast cell degranulation (GO:0043306) | 3.22948280 |
| 83 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.22624136 |
| 84 | negative T cell selection (GO:0043383) | 3.19208914 |
| 85 | dendritic cell migration (GO:0036336) | 3.19077310 |
| 86 | regulation of mast cell activation (GO:0033003) | 3.19002167 |
| 87 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.18239665 |
| 88 | B cell mediated immunity (GO:0019724) | 3.17934357 |
| 89 | positive regulation of interferon-beta production (GO:0032728) | 3.16343494 |
| 90 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.16261361 |
| 91 | positive regulation of T cell migration (GO:2000406) | 3.13770558 |
| 92 | T cell migration (GO:0072678) | 3.12701089 |
| 93 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.12585015 |
| 94 | regulation of interleukin-17 production (GO:0032660) | 3.11318537 |
| 95 | neutrophil mediated immunity (GO:0002446) | 3.10620619 |
| 96 | detection of other organism (GO:0098543) | 3.10358663 |
| 97 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.09680837 |
| 98 | positive regulation of heat generation (GO:0031652) | 3.08946532 |
| 99 | negative thymic T cell selection (GO:0045060) | 3.08857494 |
| 100 | regulation of B cell differentiation (GO:0045577) | 3.08389772 |
| 101 | definitive hemopoiesis (GO:0060216) | 3.07106145 |
| 102 | positive regulation of B cell differentiation (GO:0045579) | 3.06258987 |
| 103 | negative regulation of T cell mediated immunity (GO:0002710) | 3.05445934 |
| 104 | mast cell activation involved in immune response (GO:0002279) | 3.04572863 |
| 105 | mast cell degranulation (GO:0043303) | 3.04572863 |
| 106 | DNA deamination (GO:0045006) | 3.04147766 |
| 107 | positive regulation of defense response to virus by host (GO:0002230) | 3.03930892 |
| 108 | regulation of mast cell degranulation (GO:0043304) | 3.03236077 |
| 109 | detection of external biotic stimulus (GO:0098581) | 3.03045170 |
| 110 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.02924573 |
| 111 | regulation of tolerance induction (GO:0002643) | 3.02338989 |
| 112 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.01638262 |
| 113 | regulation of fever generation (GO:0031620) | 3.01370960 |
| 114 | positive regulation of T cell chemotaxis (GO:0010820) | 3.00873866 |
| 115 | regulation of T cell chemotaxis (GO:0010819) | 3.00873866 |
| 116 | myeloid leukocyte activation (GO:0002274) | 3.00155720 |
| 117 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.00077733 |
| 118 | positive T cell selection (GO:0043368) | 2.99467103 |
| 119 | regulation of antigen processing and presentation (GO:0002577) | 2.99173162 |
| 120 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.99018870 |
| 121 | myeloid dendritic cell differentiation (GO:0043011) | 2.98912612 |
| 122 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.98489078 |
| 123 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.98445840 |
| 124 | natural killer cell mediated immunity (GO:0002228) | 2.98445840 |
| 125 | histamine secretion (GO:0001821) | 2.98377537 |
| 126 | regulation of activation of Janus kinase activity (GO:0010533) | 2.97251059 |
| 127 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.97177573 |
| 128 | cellular response to zinc ion (GO:0071294) | 2.97033337 |
| 129 | platelet dense granule organization (GO:0060155) | 2.96764495 |
| 130 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.96730290 |
| 131 | leukocyte aggregation (GO:0070486) | 2.95168881 |
| 132 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.94239168 |
| 133 | endosome to melanosome transport (GO:0035646) | 2.93563940 |
| 134 | endosome to pigment granule transport (GO:0043485) | 2.93563940 |
| 135 | positive regulation of type 2 immune response (GO:0002830) | 2.93413360 |
| 136 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.93241443 |
| 137 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.92101604 |
| 138 | macrophage activation (GO:0042116) | 2.91794078 |
| 139 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.91783567 |
| 140 | negative regulation of phagocytosis (GO:0050765) | 2.91514474 |
| 141 | positive regulation of interleukin-17 production (GO:0032740) | 2.91161395 |
| 142 | positive regulation of interleukin-12 production (GO:0032735) | 2.91112346 |
| 143 | negative regulation of B cell proliferation (GO:0030889) | 2.90382596 |
| 144 | myeloid leukocyte mediated immunity (GO:0002444) | 2.88076504 |
| 145 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.88039037 |
| 146 | dendritic cell chemotaxis (GO:0002407) | 2.88027746 |
| 147 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.87009861 |
| 148 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.86994427 |
| 149 | doxorubicin metabolic process (GO:0044598) | 2.86718889 |
| 150 | daunorubicin metabolic process (GO:0044597) | 2.86718889 |
| 151 | cellular response to interferon-gamma (GO:0071346) | 2.85967114 |
| 152 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.84386657 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.19693405 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.07175514 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.31956385 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.09753563 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.54999267 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.64301285 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.56549532 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.29830668 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.20399164 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.07387113 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.97028170 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.95863034 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.87004321 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.67575964 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.59539541 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.51308335 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.41066367 |
| 18 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.24568675 |
| 19 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.08686641 |
| 20 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08663839 |
| 21 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.98072749 |
| 22 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97262238 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.95243428 |
| 24 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.88686959 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 1.83986618 |
| 26 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.79756397 |
| 27 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.75225798 |
| 28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.72034458 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.71458995 |
| 30 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69023925 |
| 31 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.67822988 |
| 32 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.66028373 |
| 33 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.65557757 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.63093139 |
| 35 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.56147958 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.52135172 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.50452108 |
| 38 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.48372440 |
| 39 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.48337926 |
| 40 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.48039034 |
| 41 | MYB_26560356_Chip-Seq_TH2_Human | 1.45031763 |
| 42 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.40789339 |
| 43 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.40670405 |
| 44 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.38822661 |
| 45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.37966562 |
| 46 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37244989 |
| 47 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.36021734 |
| 48 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.32677723 |
| 49 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.31706449 |
| 50 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30389030 |
| 51 | MAF_26560356_Chip-Seq_TH1_Human | 1.28322039 |
| 52 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.26257514 |
| 53 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25472287 |
| 54 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24757859 |
| 55 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.23312231 |
| 56 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23163581 |
| 57 | MYB_26560356_Chip-Seq_TH1_Human | 1.21200203 |
| 58 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.19160023 |
| 59 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18518581 |
| 60 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.17721784 |
| 61 | GATA3_26560356_Chip-Seq_TH2_Human | 1.16978807 |
| 62 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.16580318 |
| 63 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.14773804 |
| 64 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14159225 |
| 65 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.12081080 |
| 66 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11221868 |
| 67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11000343 |
| 68 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.10198108 |
| 69 | SPI1_23127762_ChIP-Seq_K562_Human | 1.09806107 |
| 70 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.08821582 |
| 71 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.08327024 |
| 72 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.08141630 |
| 73 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.08127659 |
| 74 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.07428076 |
| 75 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.07120057 |
| 76 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.05964012 |
| 77 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.05380296 |
| 78 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05108496 |
| 79 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05067218 |
| 80 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04700304 |
| 81 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.03172149 |
| 82 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.03071348 |
| 83 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.02244776 |
| 84 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02036700 |
| 85 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01886168 |
| 86 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.01299337 |
| 87 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.00711213 |
| 88 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.00569901 |
| 89 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.99049689 |
| 90 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.98908871 |
| 91 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.98090697 |
| 92 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.97296464 |
| 93 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96630286 |
| 94 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96552181 |
| 95 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.95398123 |
| 96 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95388642 |
| 97 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.95285092 |
| 98 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94691029 |
| 99 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.93796339 |
| 100 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.93451713 |
| 101 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.93403022 |
| 102 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.89717732 |
| 103 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89269017 |
| 104 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.87946243 |
| 105 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.87758730 |
| 106 | MAF_26560356_Chip-Seq_TH2_Human | 0.87483093 |
| 107 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.87300101 |
| 108 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86922124 |
| 109 | GATA3_26560356_Chip-Seq_TH1_Human | 0.86546555 |
| 110 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.86541363 |
| 111 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.85789296 |
| 112 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.85561887 |
| 113 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.84893896 |
| 114 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.84100071 |
| 115 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.83491040 |
| 116 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.82708235 |
| 117 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.80675280 |
| 118 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.80639725 |
| 119 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.80528718 |
| 120 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.79821278 |
| 121 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.78768563 |
| 122 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78415574 |
| 123 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.78069780 |
| 124 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78004202 |
| 125 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.77861221 |
| 126 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.76269576 |
| 127 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.76176223 |
| 128 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75685774 |
| 129 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.75448320 |
| 130 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.72020249 |
| 131 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.71869292 |
| 132 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.71392760 |
| 133 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.71392760 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.40882582 |
| 2 | MP0009785_altered_susceptibility_to | 4.23773926 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 4.04443220 |
| 4 | MP0003436_decreased_susceptibility_to | 3.30419583 |
| 5 | MP0003724_increased_susceptibility_to | 3.26451487 |
| 6 | MP0005025_abnormal_response_to | 3.16082336 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.15902959 |
| 8 | MP0002419_abnormal_innate_immunity | 3.12880976 |
| 9 | MP0005671_abnormal_response_to | 3.06733531 |
| 10 | MP0006082_CNS_inflammation | 2.95728430 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.71763753 |
| 12 | MP0005464_abnormal_platelet_physiology | 2.70795515 |
| 13 | MP0002723_abnormal_immune_serum | 2.64320175 |
| 14 | MP0000685_abnormal_immune_system | 2.63929200 |
| 15 | MP0005451_abnormal_body_composition | 2.62934111 |
| 16 | MP0005387_immune_system_phenotype | 2.60653840 |
| 17 | MP0001790_abnormal_immune_system | 2.60653840 |
| 18 | MP0001800_abnormal_humoral_immune | 2.53744964 |
| 19 | MP0001819_abnormal_immune_cell | 2.39926372 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.36332269 |
| 21 | MP0005397_hematopoietic_system_phenotyp | 2.16034351 |
| 22 | MP0001545_abnormal_hematopoietic_system | 2.16034351 |
| 23 | MP0009764_decreased_sensitivity_to | 2.07704411 |
| 24 | MP0001853_heart_inflammation | 2.03857935 |
| 25 | MP0004510_myositis | 1.92750529 |
| 26 | MP0008877_abnormal_DNA_methylation | 1.86739802 |
| 27 | MP0002006_tumorigenesis | 1.84750337 |
| 28 | MP0002398_abnormal_bone_marrow | 1.80466957 |
| 29 | MP0000716_abnormal_immune_system | 1.78275385 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.76013831 |
| 31 | MP0003303_peritoneal_inflammation | 1.74554665 |
| 32 | MP0002405_respiratory_system_inflammati | 1.73611551 |
| 33 | MP0005310_abnormal_salivary_gland | 1.72846109 |
| 34 | MP0005058_abnormal_lysosome_morphology | 1.70287628 |
| 35 | MP0003787_abnormal_imprinting | 1.68282078 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.65814617 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.64677277 |
| 38 | MP0000372_irregular_coat_pigmentation | 1.64185145 |
| 39 | MP0004782_abnormal_surfactant_physiolog | 1.63015978 |
| 40 | MP0008469_abnormal_protein_level | 1.62651537 |
| 41 | MP0003763_abnormal_thymus_physiology | 1.61773819 |
| 42 | MP0005174_abnormal_tail_pigmentation | 1.59096550 |
| 43 | MP0003806_abnormal_nucleotide_metabolis | 1.57932432 |
| 44 | MP0002396_abnormal_hematopoietic_system | 1.57001707 |
| 45 | MP0004808_abnormal_hematopoietic_stem | 1.52143106 |
| 46 | MP0000343_altered_response_to | 1.49966896 |
| 47 | MP0002429_abnormal_blood_cell | 1.48852966 |
| 48 | MP0003183_abnormal_peptide_metabolism | 1.48356544 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.44364111 |
| 50 | MP0003172_abnormal_lysosome_physiology | 1.42339483 |
| 51 | MP0000689_abnormal_spleen_morphology | 1.38553756 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.36810500 |
| 53 | MP0002009_preneoplasia | 1.36224576 |
| 54 | MP0003075_altered_response_to | 1.28264187 |
| 55 | MP0002722_abnormal_immune_system | 1.28016049 |
| 56 | MP0009697_abnormal_copulation | 1.27626464 |
| 57 | MP0000015_abnormal_ear_pigmentation | 1.26529808 |
| 58 | MP0002277_abnormal_respiratory_mucosa | 1.23603948 |
| 59 | MP0000490_abnormal_crypts_of | 1.22466366 |
| 60 | MP0004883_abnormal_blood_vessel | 1.21246400 |
| 61 | MP0005075_abnormal_melanosome_morpholog | 1.13314769 |
| 62 | MP0008260_abnormal_autophagy | 1.12210850 |
| 63 | MP0005166_decreased_susceptibility_to | 1.12006067 |
| 64 | MP0005167_abnormal_blood-brain_barrier | 1.10242137 |
| 65 | MP0006292_abnormal_olfactory_placode | 1.09567929 |
| 66 | MP0004381_abnormal_hair_follicle | 1.08069550 |
| 67 | MP0004947_skin_inflammation | 1.07627850 |
| 68 | MP0003448_altered_tumor_morphology | 1.07071903 |
| 69 | MP0002998_abnormal_bone_remodeling | 1.05530221 |
| 70 | MP0003136_yellow_coat_color | 1.03809420 |
| 71 | MP0003186_abnormal_redox_activity | 1.02774768 |
| 72 | MP0000371_diluted_coat_color | 1.02573647 |
| 73 | MP0002132_abnormal_respiratory_system | 1.00745309 |
| 74 | MP0000858_altered_metastatic_potential | 0.99971881 |
| 75 | MP0008057_abnormal_DNA_replication | 0.98931782 |
| 76 | MP0009278_abnormal_bone_marrow | 0.98386304 |
| 77 | MP0009763_increased_sensitivity_to | 0.95228604 |
| 78 | MP0003828_pulmonary_edema | 0.95135484 |
| 79 | MP0000569_abnormal_digit_pigmentation | 0.94000164 |
| 80 | MP0002095_abnormal_skin_pigmentation | 0.93574432 |
| 81 | MP0002876_abnormal_thyroid_physiology | 0.92780240 |
| 82 | MP0000681_abnormal_thyroid_gland | 0.90707384 |
| 83 | MP0002166_altered_tumor_susceptibility | 0.90683827 |
| 84 | MP0003866_abnormal_defecation | 0.85833842 |
| 85 | MP0002019_abnormal_tumor_incidence | 0.85814866 |
| 86 | MP0001986_abnormal_taste_sensitivity | 0.85359328 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 0.84349574 |
| 88 | MP0002933_joint_inflammation | 0.83288058 |
| 89 | MP0001851_eye_inflammation | 0.81524995 |
| 90 | MP0003943_abnormal_hepatobiliary_system | 0.78478012 |
| 91 | MP0003191_abnormal_cellular_cholesterol | 0.78192922 |
| 92 | MP0005171_absent_coat_pigmentation | 0.77801886 |
| 93 | MP0008007_abnormal_cellular_replicative | 0.76532531 |
| 94 | MP0000703_abnormal_thymus_morphology | 0.74783602 |
| 95 | MP0003300_gastrointestinal_ulcer | 0.73608502 |
| 96 | MP0005390_skeleton_phenotype | 0.72382919 |
| 97 | MP0008872_abnormal_physiological_respon | 0.71835612 |
| 98 | MP0005409_darkened_coat_color | 0.71807069 |
| 99 | MP0002332_abnormal_exercise_endurance | 0.70869003 |
| 100 | MP0000465_gastrointestinal_hemorrhage | 0.70684805 |
| 101 | MP0006054_spinal_hemorrhage | 0.70657552 |
| 102 | MP0005164_abnormal_response_to | 0.68542000 |
| 103 | MP0004484_altered_response_of | 0.66732757 |
| 104 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.66330590 |
| 105 | MP0002075_abnormal_coat/hair_pigmentati | 0.66255022 |
| 106 | MP0003690_abnormal_glial_cell | 0.65148181 |
| 107 | MP0001188_hyperpigmentation | 0.64318536 |
| 108 | MP0005376_homeostasis/metabolism_phenot | 0.63507344 |
| 109 | MP0000566_synostosis | 0.63414163 |
| 110 | MP0001186_pigmentation_phenotype | 0.62722886 |
| 111 | MP0002693_abnormal_pancreas_physiology | 0.60485106 |
| 112 | MP0008873_increased_physiological_sensi | 0.59659487 |
| 113 | MP0002163_abnormal_gland_morphology | 0.59379161 |
| 114 | MP0001873_stomach_inflammation | 0.59062145 |
| 115 | MP0003693_abnormal_embryo_hatching | 0.58944919 |
| 116 | MP0000230_abnormal_systemic_arterial | 0.58385706 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.57323981 |
| 118 | MP0008058_abnormal_DNA_repair | 0.56718637 |
| 119 | MP0004130_abnormal_muscle_cell | 0.56288452 |
| 120 | MP0002127_abnormal_cardiovascular_syste | 0.54960149 |
| 121 | MP0001542_abnormal_bone_strength | 0.54453374 |
| 122 | MP0001663_abnormal_digestive_system | 0.53388639 |
| 123 | MP0005266_abnormal_metabolism | 0.53172727 |
| 124 | MP0000249_abnormal_blood_vessel | 0.52698075 |
| 125 | MP0002938_white_spotting | 0.52014015 |
| 126 | MP0005645_abnormal_hypothalamus_physiol | 0.51504423 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.85182536 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.30324866 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.23825086 |
| 4 | T lymphocytopenia (HP:0005403) | 5.66797289 |
| 5 | Abnormality of B cell number (HP:0010975) | 5.36596634 |
| 6 | B lymphocytopenia (HP:0010976) | 5.34641922 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.21115031 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 4.48412263 |
| 9 | Severe combined immunodeficiency (HP:0004430) | 4.46276699 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.43075407 |
| 11 | Thyroiditis (HP:0100646) | 4.42555230 |
| 12 | Hypoplasia of the thymus (HP:0000778) | 4.35906710 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.31208492 |
| 14 | Stomatitis (HP:0010280) | 4.11452528 |
| 15 | Recurrent skin infections (HP:0001581) | 3.95036365 |
| 16 | Autoimmune thrombocytopenia (HP:0001973) | 3.84701610 |
| 17 | Vasculitis (HP:0002633) | 3.79972252 |
| 18 | Recurrent fungal infections (HP:0002841) | 3.77575238 |
| 19 | Myositis (HP:0100614) | 3.76315115 |
| 20 | Chronic otitis media (HP:0000389) | 3.71449826 |
| 21 | Obstructive lung disease (HP:0006536) | 3.68358099 |
| 22 | Chronic obstructive pulmonary disease (HP:0006510) | 3.68358099 |
| 23 | Retrobulbar optic neuritis (HP:0100654) | 3.60440171 |
| 24 | Optic neuritis (HP:0100653) | 3.60440171 |
| 25 | Gingivitis (HP:0000230) | 3.53958233 |
| 26 | Abnormality of eosinophils (HP:0001879) | 3.46928156 |
| 27 | Recurrent viral infections (HP:0004429) | 3.45959319 |
| 28 | Petechiae (HP:0000967) | 3.42644621 |
| 29 | Combined immunodeficiency (HP:0005387) | 3.40310760 |
| 30 | Increased IgM level (HP:0003496) | 3.27333864 |
| 31 | Orchitis (HP:0100796) | 3.27266750 |
| 32 | Vacuolated lymphocytes (HP:0001922) | 3.22874468 |
| 33 | Basal ganglia calcification (HP:0002135) | 3.19651259 |
| 34 | Prolonged bleeding time (HP:0003010) | 3.14038193 |
| 35 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.10867424 |
| 36 | Gastrointestinal infarctions (HP:0005244) | 3.09192752 |
| 37 | Recurrent cutaneous fungal infections (HP:0011370) | 3.07347817 |
| 38 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.07347817 |
| 39 | Disinhibition (HP:0000734) | 2.98686456 |
| 40 | Meningitis (HP:0001287) | 2.87181706 |
| 41 | Purpura (HP:0000979) | 2.83074474 |
| 42 | Chest pain (HP:0100749) | 2.70644617 |
| 43 | Cellulitis (HP:0100658) | 2.69948870 |
| 44 | Gingival bleeding (HP:0000225) | 2.69827139 |
| 45 | Periodontitis (HP:0000704) | 2.68066404 |
| 46 | Recurrent pneumonia (HP:0006532) | 2.67878909 |
| 47 | Pulmonary embolism (HP:0002204) | 2.67281466 |
| 48 | Urticaria (HP:0001025) | 2.65835703 |
| 49 | Increased cerebral lipofuscin (HP:0011813) | 2.65226702 |
| 50 | Hypergammaglobulinemia (HP:0010702) | 2.62812190 |
| 51 | Increased IgE level (HP:0003212) | 2.56872192 |
| 52 | IgM deficiency (HP:0002850) | 2.56221087 |
| 53 | Interstitial pulmonary disease (HP:0006530) | 2.55694970 |
| 54 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.55031046 |
| 55 | Autoimmune hemolytic anemia (HP:0001890) | 2.54473549 |
| 56 | Spontaneous hematomas (HP:0007420) | 2.50591433 |
| 57 | Stomach cancer (HP:0012126) | 2.50023981 |
| 58 | Abnormality of T cell physiology (HP:0011840) | 2.47917434 |
| 59 | Aplastic anemia (HP:0001915) | 2.46879741 |
| 60 | Prostate neoplasm (HP:0100787) | 2.46562808 |
| 61 | Gangrene (HP:0100758) | 2.45629975 |
| 62 | Osteomyelitis (HP:0002754) | 2.44759031 |
| 63 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.43859866 |
| 64 | Recurrent lower respiratory tract infections (HP:0002783) | 2.40644878 |
| 65 | Epistaxis (HP:0000421) | 2.39467783 |
| 66 | Skin rash (HP:0000988) | 2.35185022 |
| 67 | Abnormality of the prostate (HP:0008775) | 2.35119858 |
| 68 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.32798383 |
| 69 | Thrombocytosis (HP:0001894) | 2.28031787 |
| 70 | Pulmonary infiltrates (HP:0002113) | 2.27579919 |
| 71 | Visual hallucinations (HP:0002367) | 2.24407753 |
| 72 | Keratoconjunctivitis sicca (HP:0001097) | 2.20080445 |
| 73 | Verrucae (HP:0200043) | 2.19497096 |
| 74 | Papilloma (HP:0012740) | 2.19497096 |
| 75 | Episodic fever (HP:0001954) | 2.19448881 |
| 76 | Leukocytosis (HP:0001974) | 2.17892340 |
| 77 | Reduced antithrombin III activity (HP:0001976) | 2.17498831 |
| 78 | Encephalitis (HP:0002383) | 2.17466695 |
| 79 | Chronic diarrhea (HP:0002028) | 2.17334665 |
| 80 | Menorrhagia (HP:0000132) | 2.15857913 |
| 81 | Lymphopenia (HP:0001888) | 2.15850188 |
| 82 | Poor head control (HP:0002421) | 2.13423709 |
| 83 | Hypoproteinemia (HP:0003075) | 2.13114961 |
| 84 | Agammaglobulinemia (HP:0004432) | 2.12093301 |
| 85 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.12006129 |
| 86 | Amyotrophic lateral sclerosis (HP:0007354) | 2.11576813 |
| 87 | Arterial thrombosis (HP:0004420) | 2.11162439 |
| 88 | Anorexia (HP:0002039) | 2.10911256 |
| 89 | Hypothermia (HP:0002045) | 2.10718862 |
| 90 | Abnormality of T cells (HP:0002843) | 2.10468945 |
| 91 | Inflammation of the large intestine (HP:0002037) | 2.10260905 |
| 92 | Pustule (HP:0200039) | 2.10120240 |
| 93 | Albinism (HP:0001022) | 2.09968819 |
| 94 | Chromsome breakage (HP:0040012) | 2.08489030 |
| 95 | IgG deficiency (HP:0004315) | 2.08423300 |
| 96 | Neutropenia (HP:0001875) | 2.06598185 |
| 97 | Hepatosplenomegaly (HP:0001433) | 2.03947378 |
| 98 | Hypochromic microcytic anemia (HP:0004840) | 2.03671151 |
| 99 | Hemoptysis (HP:0002105) | 2.03059469 |
| 100 | Gastrointestinal stroma tumor (HP:0100723) | 2.02834375 |
| 101 | Premature loss of primary teeth (HP:0006323) | 2.02805185 |
| 102 | Panhypogammaglobulinemia (HP:0003139) | 2.01159418 |
| 103 | Gastrointestinal inflammation (HP:0004386) | 2.00809510 |
| 104 | Keratoconjunctivitis (HP:0001096) | 2.00174929 |
| 105 | Inappropriate behavior (HP:0000719) | 1.99349717 |
| 106 | Polyneuropathy (HP:0001271) | 1.98929134 |
| 107 | Viral hepatitis (HP:0006562) | 1.98719097 |
| 108 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.97658405 |
| 109 | Acute lymphatic leukemia (HP:0006721) | 1.97246894 |
| 110 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.95806046 |
| 111 | Metaphyseal dysplasia (HP:0100255) | 1.95791956 |
| 112 | Neurodegeneration (HP:0002180) | 1.95678597 |
| 113 | Joint hemorrhage (HP:0005261) | 1.95547765 |
| 114 | Recurrent bronchitis (HP:0002837) | 1.94548330 |
| 115 | Joint swelling (HP:0001386) | 1.93188917 |
| 116 | Type I transferrin isoform profile (HP:0003642) | 1.93174532 |
| 117 | Tetraparesis (HP:0002273) | 1.90300051 |
| 118 | Thrombophlebitis (HP:0004418) | 1.89086930 |
| 119 | Acute hepatic failure (HP:0006554) | 1.88993720 |
| 120 | Abnormality of male internal genitalia (HP:0000022) | 1.88818444 |
| 121 | Vertigo (HP:0002321) | 1.88431866 |
| 122 | Chronic sinusitis (HP:0011109) | 1.87751430 |
| 123 | Amaurosis fugax (HP:0100576) | 1.87425981 |
| 124 | Sepsis (HP:0100806) | 1.86864697 |
| 125 | Abnormality of the basal ganglia (HP:0002134) | 1.86765744 |
| 126 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.86340283 |
| 127 | Skin ulcer (HP:0200042) | 1.86320769 |
| 128 | Constricted visual fields (HP:0001133) | 1.85181922 |
| 129 | Abnormality of glycolipid metabolism (HP:0010969) | 1.84470747 |
| 130 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.84470747 |
| 131 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.84470747 |
| 132 | Clubbing of toes (HP:0100760) | 1.84418444 |
| 133 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.81878116 |
| 134 | Abnormality of T cell number (HP:0011839) | 1.80590419 |
| 135 | Granulocytopenia (HP:0001913) | 1.80114872 |
| 136 | Eosinophilia (HP:0001880) | 1.78946686 |
| 137 | Loss of speech (HP:0002371) | 1.76777819 |
| 138 | Abnormality of the pleura (HP:0002103) | 1.75233096 |
| 139 | Syringomyelia (HP:0003396) | 1.73843564 |
| 140 | Spinal cord lesions (HP:0100561) | 1.73843564 |
| 141 | Arthralgia (HP:0002829) | 1.73803072 |
| 142 | Patchy hypopigmentation of hair (HP:0011365) | 1.73729935 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.02668179 |
| 2 | IRAK4 | 3.43672397 |
| 3 | RIPK4 | 3.18425985 |
| 4 | TXK | 3.13459776 |
| 5 | BLK | 3.12008358 |
| 6 | KIT | 2.88585909 |
| 7 | MAP4K1 | 2.67892127 |
| 8 | TBK1 | 2.57246588 |
| 9 | IKBKE | 2.45021767 |
| 10 | PIM2 | 2.36013816 |
| 11 | TEC | 2.34750623 |
| 12 | IRAK3 | 2.34461561 |
| 13 | JAK3 | 2.17187886 |
| 14 | IKBKB | 2.15180677 |
| 15 | GRK6 | 2.09119448 |
| 16 | FRK | 2.02022613 |
| 17 | PBK | 2.01315345 |
| 18 | TYK2 | 1.95756544 |
| 19 | NME2 | 1.92147206 |
| 20 | MAP3K12 | 1.88412408 |
| 21 | BMPR2 | 1.81048267 |
| 22 | MST4 | 1.71204869 |
| 23 | BTK | 1.67016507 |
| 24 | SYK | 1.57301373 |
| 25 | MATK | 1.56281026 |
| 26 | TNIK | 1.46205275 |
| 27 | CSF1R | 1.45749835 |
| 28 | ADRBK2 | 1.43388430 |
| 29 | MAP3K2 | 1.42602409 |
| 30 | NEK9 | 1.41788188 |
| 31 | MAP3K11 | 1.41495746 |
| 32 | ACVR1B | 1.39072203 |
| 33 | LYN | 1.32557089 |
| 34 | JAK1 | 1.30140517 |
| 35 | CHUK | 1.28856160 |
| 36 | PIM1 | 1.27068728 |
| 37 | STK16 | 1.25307420 |
| 38 | TRPM7 | 1.24621699 |
| 39 | ERBB3 | 1.22871000 |
| 40 | FLT3 | 1.21960669 |
| 41 | MAP3K13 | 1.20479940 |
| 42 | RPS6KA4 | 1.19688386 |
| 43 | TESK2 | 1.17671516 |
| 44 | BRD4 | 1.16410827 |
| 45 | YES1 | 1.14437475 |
| 46 | EIF2AK2 | 1.13709020 |
| 47 | SCYL2 | 1.09393809 |
| 48 | MUSK | 1.04791849 |
| 49 | ZAP70 | 1.03642248 |
| 50 | EPHA3 | 1.02831887 |
| 51 | NUAK1 | 0.98437412 |
| 52 | FGR | 0.98101648 |
| 53 | CLK1 | 0.97869927 |
| 54 | TIE1 | 0.95443544 |
| 55 | PLK2 | 0.94819409 |
| 56 | DYRK3 | 0.93380672 |
| 57 | GRK7 | 0.91639225 |
| 58 | CASK | 0.91634650 |
| 59 | CDK19 | 0.91046176 |
| 60 | ZAK | 0.88482349 |
| 61 | MARK3 | 0.88394089 |
| 62 | SIK3 | 0.88324566 |
| 63 | SRPK1 | 0.86838852 |
| 64 | STK4 | 0.86325124 |
| 65 | STK24 | 0.84224957 |
| 66 | LCK | 0.84146362 |
| 67 | CSK | 0.81045265 |
| 68 | MAPK12 | 0.80640810 |
| 69 | IRAK1 | 0.80373162 |
| 70 | HCK | 0.79007949 |
| 71 | TAOK3 | 0.76560431 |
| 72 | MAP3K5 | 0.75487167 |
| 73 | MAP3K1 | 0.74509499 |
| 74 | PRKCD | 0.71825502 |
| 75 | ABL2 | 0.71310503 |
| 76 | MAP2K7 | 0.70103362 |
| 77 | PIK3CA | 0.70026163 |
| 78 | PLK4 | 0.69052806 |
| 79 | MYLK | 0.68366680 |
| 80 | CDK8 | 0.67852971 |
| 81 | PRPF4B | 0.67785729 |
| 82 | TGFBR2 | 0.67328868 |
| 83 | MKNK1 | 0.66006941 |
| 84 | TAOK2 | 0.65271118 |
| 85 | NLK | 0.64843340 |
| 86 | BMPR1B | 0.64377053 |
| 87 | GRK1 | 0.59892152 |
| 88 | CCNB1 | 0.58311087 |
| 89 | KDR | 0.57516717 |
| 90 | PTK2B | 0.57349587 |
| 91 | FES | 0.56914246 |
| 92 | PINK1 | 0.56525173 |
| 93 | FYN | 0.53670029 |
| 94 | VRK1 | 0.53559106 |
| 95 | MAPK7 | 0.53552767 |
| 96 | PRKG2 | 0.53185720 |
| 97 | STK11 | 0.52920565 |
| 98 | EPHB1 | 0.52085132 |
| 99 | OXSR1 | 0.51857811 |
| 100 | MAP4K2 | 0.51664942 |
| 101 | MAP2K6 | 0.50856824 |
| 102 | PDK1 | 0.50825655 |
| 103 | RPS6KA5 | 0.50225377 |
| 104 | PRKCQ | 0.49840776 |
| 105 | INSRR | 0.48712281 |
| 106 | FGFR3 | 0.48363647 |
| 107 | IRAK2 | 0.48164119 |
| 108 | MAP2K3 | 0.47738917 |
| 109 | TNK2 | 0.46747049 |
| 110 | EGFR | 0.46517012 |
| 111 | JAK2 | 0.46232227 |
| 112 | MAPK13 | 0.45905588 |
| 113 | MAPKAPK3 | 0.44928673 |
| 114 | MAP3K3 | 0.44801510 |
| 115 | EIF2AK1 | 0.43185904 |
| 116 | IGF1R | 0.43060434 |
| 117 | LRRK2 | 0.42866346 |
| 118 | RPS6KA6 | 0.42615129 |
| 119 | DAPK1 | 0.42433874 |
| 120 | ERN1 | 0.41318397 |
| 121 | ITK | 0.41243377 |
| 122 | ABL1 | 0.40730026 |
| 123 | WNK1 | 0.39221375 |
| 124 | GRK5 | 0.38489148 |
| 125 | CAMKK2 | 0.36942103 |
| 126 | MKNK2 | 0.35798579 |
| 127 | MAP2K4 | 0.34605491 |
| 128 | ATR | 0.33490066 |
| 129 | MAP3K6 | 0.29594060 |
| 130 | ERBB2 | 0.27215903 |
| 131 | RAF1 | 0.26739714 |
| 132 | BCR | 0.25882005 |
| 133 | DAPK2 | 0.25848379 |
| 134 | PIK3CG | 0.25484858 |
| 135 | MAPK11 | 0.24941426 |
| 136 | NEK6 | 0.24779944 |
| 137 | RPS6KB1 | 0.24154068 |
| 138 | OBSCN | 0.23959996 |
| 139 | EIF2AK3 | 0.22156381 |
| 140 | MAPKAPK2 | 0.20378557 |
| 141 | ADRBK1 | 0.19124771 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.48788634 |
| 2 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.39411602 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.29668950 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 3.09772383 |
| 5 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.67350544 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.67258488 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.64064700 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.49662483 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.47120419 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.44066332 |
| 11 | Measles_Homo sapiens_hsa05162 | 2.25380833 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.24069707 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.21943861 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.12785223 |
| 15 | Asthma_Homo sapiens_hsa05310 | 2.11899965 |
| 16 | Pertussis_Homo sapiens_hsa05133 | 2.05481835 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.99831724 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.96891368 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 1.96503618 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.95454390 |
| 21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.89982513 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.85225473 |
| 23 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.73441245 |
| 24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.71976312 |
| 25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.69473629 |
| 26 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.68931982 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.58279362 |
| 28 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.56892126 |
| 29 | Phagosome_Homo sapiens_hsa04145 | 1.42445569 |
| 30 | Salmonella infection_Homo sapiens_hsa05132 | 1.42275509 |
| 31 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.39582568 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.36297356 |
| 33 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.33761063 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32600676 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26540675 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.22877559 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.19291029 |
| 38 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.18468874 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.17096585 |
| 40 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05889159 |
| 41 | Homologous recombination_Homo sapiens_hsa03440 | 1.04940079 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.03743753 |
| 43 | DNA replication_Homo sapiens_hsa03030 | 1.03564926 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.03318747 |
| 45 | Base excision repair_Homo sapiens_hsa03410 | 1.02132341 |
| 46 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.01730794 |
| 47 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.00629122 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 0.97433439 |
| 49 | Hepatitis B_Homo sapiens_hsa05161 | 0.95105919 |
| 50 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.88882115 |
| 51 | Proteasome_Homo sapiens_hsa03050 | 0.88444938 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 0.88210639 |
| 53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.78066038 |
| 54 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.76658571 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.74933348 |
| 56 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.73654854 |
| 57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.70244927 |
| 58 | Viral myocarditis_Homo sapiens_hsa05416 | 0.64912166 |
| 59 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.64276987 |
| 60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.61184958 |
| 61 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.60309423 |
| 62 | Mismatch repair_Homo sapiens_hsa03430 | 0.57660667 |
| 63 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.56814450 |
| 64 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.56365142 |
| 65 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56035494 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55762764 |
| 67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.55464440 |
| 68 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53639000 |
| 69 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.52562174 |
| 70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.50448259 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49737406 |
| 72 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.49424247 |
| 73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.48990488 |
| 74 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48939925 |
| 75 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.46504997 |
| 76 | Amoebiasis_Homo sapiens_hsa05146 | 0.43212669 |
| 77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43210437 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43071993 |
| 79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42236729 |
| 80 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.41795658 |
| 81 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.41195090 |
| 82 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.40641773 |
| 83 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.40634233 |
| 84 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38535771 |
| 85 | RNA degradation_Homo sapiens_hsa03018 | 0.37533644 |
| 86 | Peroxisome_Homo sapiens_hsa04146 | 0.37508177 |
| 87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.35957862 |
| 88 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.35855641 |
| 89 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.35617498 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.35144615 |
| 91 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34695576 |
| 92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.33632485 |
| 93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.33354691 |
| 94 | Basal transcription factors_Homo sapiens_hsa03022 | 0.32853031 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32511919 |
| 96 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.32434605 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31837070 |
| 98 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.31019150 |
| 99 | Protein export_Homo sapiens_hsa03060 | 0.30569989 |
| 100 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.27621297 |
| 101 | RNA polymerase_Homo sapiens_hsa03020 | 0.27495479 |
| 102 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.27397239 |
| 103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.27107463 |
| 104 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.26675646 |
| 105 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.26667148 |
| 106 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.25942346 |
| 107 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.25796189 |
| 108 | Olfactory transduction_Homo sapiens_hsa04740 | 0.25627149 |
| 109 | Renin secretion_Homo sapiens_hsa04924 | 0.24553568 |
| 110 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.23142847 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.22619924 |
| 112 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22585238 |
| 113 | Long-term depression_Homo sapiens_hsa04730 | 0.22019689 |
| 114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.21488118 |
| 115 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.20954346 |
| 116 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.20779532 |
| 117 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.20322592 |
| 118 | ABC transporters_Homo sapiens_hsa02010 | 0.19670241 |
| 119 | Purine metabolism_Homo sapiens_hsa00230 | 0.19399054 |
| 120 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.19075340 |
| 121 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.17568780 |
| 122 | Ribosome_Homo sapiens_hsa03010 | 0.16915268 |
| 123 | Salivary secretion_Homo sapiens_hsa04970 | 0.15480035 |
| 124 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.15419958 |
| 125 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.15333661 |
| 126 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.14372842 |
| 127 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.12834060 |
| 128 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.09969663 |
| 129 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.09445811 |
| 130 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.08307447 |
| 131 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.08266276 |

